Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Maher

Showing results (31-40 of 134) with videos related to

Pageof 14
Sort By:
Cells|March 27, 2026
Re-Tooling of γδ T Cells for Cancer Immunotherapy Using Advanced Manufacturing and Genetic EngineeringBenjamin J L Lim, John Maher
Translational Cancer Research|June 17, 2024
The role of CD4<sup>+</sup> CAR T cells in cancer immunotherapyCamilla Bove, John Maher, Maya Glover
Hemasphere|August 11, 2025
Harnessing the immunotherapeutic potentials of gamma delta T cells against hematological malignanciesCharles Agbuduwe, John Maher, John Anderson
Foot (Edinburgh, Scotland)|March 24, 2010
A report of UK experience in 917 cases of day care foot surgery using a validated outcome toolAnthony John Maher, Stuart A Metcalfe
Biologics : Targets & Therapy|May 27, 2021
How Can We Engineer CAR T Cells to Overcome Resistance?Maya Glover, Stephanie Avraamides, John Maher
Immunopharmacology and Immunotoxicology|October 17, 2015
Prospects for adoptive immunotherapy of pancreatic cancer using chimeric antigen receptor-engineered T-cellsDoraid Alrifai, Debashis Sarker, John Maher
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 29, 2014
The effect of clinical inertia on the management of blood pressureJohn Maher, Mel Bates, Patricia Carmody
Biochemical Society Transactions|April 13, 2016
The role of the HGF/Met axis in mesotheliomaThivyan Thayaparan, James F Spicer, John Maher
Translational Lung Cancer Research|April 11, 2024
Challenges and considerations in the immunotherapy of DLL3-positive small-cell lung cancer using IL-18 armoured chimeric antigen receptor T-cellsRoberta Mazza, John Maher, Caroline M Hull
Expert Review of Anticancer Therapy|October 28, 2024
Optimising CAR T therapy for the treatment of solid tumorsNorhan Mobark, Caroline Malai Hull, John Maher
Pageof 14

Showing results (31-40 of 134) with videos related to

Sort By:
Pageof 14
Cells|March 27, 2026
Re-Tooling of γδ T Cells for Cancer Immunotherapy Using Advanced Manufacturing and Genetic EngineeringBenjamin J L Lim, John Maher
Translational Cancer Research|June 17, 2024
The role of CD4<sup>+</sup> CAR T cells in cancer immunotherapyCamilla Bove, John Maher, Maya Glover
Hemasphere|August 11, 2025
Harnessing the immunotherapeutic potentials of gamma delta T cells against hematological malignanciesCharles Agbuduwe, John Maher, John Anderson
Foot (Edinburgh, Scotland)|March 24, 2010
A report of UK experience in 917 cases of day care foot surgery using a validated outcome toolAnthony John Maher, Stuart A Metcalfe
Biologics : Targets & Therapy|May 27, 2021
How Can We Engineer CAR T Cells to Overcome Resistance?Maya Glover, Stephanie Avraamides, John Maher
Immunopharmacology and Immunotoxicology|October 17, 2015
Prospects for adoptive immunotherapy of pancreatic cancer using chimeric antigen receptor-engineered T-cellsDoraid Alrifai, Debashis Sarker, John Maher
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 29, 2014
The effect of clinical inertia on the management of blood pressureJohn Maher, Mel Bates, Patricia Carmody
Biochemical Society Transactions|April 13, 2016
The role of the HGF/Met axis in mesotheliomaThivyan Thayaparan, James F Spicer, John Maher
Translational Lung Cancer Research|April 11, 2024
Challenges and considerations in the immunotherapy of DLL3-positive small-cell lung cancer using IL-18 armoured chimeric antigen receptor T-cellsRoberta Mazza, John Maher, Caroline M Hull
Expert Review of Anticancer Therapy|October 28, 2024
Optimising CAR T therapy for the treatment of solid tumorsNorhan Mobark, Caroline Malai Hull, John Maher
Pageof 14